Navigation Links
Chimerix Appoints Michael D. Rogers, Ph.D., as Chief Development Officer
Date:3/14/2013

aster of Public Health and Ph.D. from the University of North Carolina at Chapel Hill and was a postdoctoral fellow in Clinical Microbiology at St. Jude Children's Hospital.

About Chimerix and CMX001
Chimerix is committed to the discovery, development and commercialization of novel, oral antiviral therapeutics designed to transform patient care in areas of high unmet medical need.  The Company's proprietary lipid technology has given rise to two clinical-stage lipid acyclic nucleoside phosphonates, CMX001 and CMX157, which have demonstrated the potential for enhanced activity and safety in convenient, orally administered dosing regimens.

Chimerix's lead product candidate, CMX001, is a broad spectrum, oral nucleotide analog lipid-conjugate that blocks replication of double-stranded DNA (dsDNA) viruses, including cytomegalovirus (CMV), adenovirus (AdV), BK virus and herpes simplex virus.  CMX001 has completed Phase 2 clinical development for the prevention of CMV in hematopoietic stem cell transplant (HSCT) recipients.  Chimerix is also conducting a Phase 2 study in HSCT recipients which is evaluating CMX001 as a preemptive therapy for AdV disease, an often-fatal infection which has no approved therapies.  Since 2009, Chimerix has made CMX001 available under expanded access regulations to over 80 transplant centers worldwide for the treatment of over 430 patients with life-threatening dsDNA viral infections.  Chimerix anticipates initiating SUPPRESS, its Phase 3 study of CMX001 for the prevention of CMV infection in adults undergoing HSCT, in 2013.   

Chimerix is also developing CMX001 as a potential medical countermeasure against smallpox under a contract from the Biomedical Advanced Research and Development Authority (BARDA). 

Chimerix's second product candidate, CMX157, an oral nucleotide analog lipid-conjugate in Phase 1 development for the treatment of HIV infection, was licensed to M
'/>"/>

SOURCE Chimerix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Grants Chimerix Fast Track Designation for CMX001 for the Prevention of Clinically Significant Cytomegalovirus Infection
2. Chimerix Files Registration Statement for Proposed Initial Public Offering
3. Data Demonstrating the Safety and Efficacy of Chimerixs Antiviral CMX001 Presented at BMT Tandem Meetings
4. Data Related to Chimerixs Antiviral CMX001 to be Presented in Three Poster Sessions at the BMT Tandem Meetings
5. Chimerix Presents Data Highlighting Burden Of Care Associated With Current Antiviral Therapies In Stem Cell Transplantation
6. Chimerix Signs Worldwide License Agreement With Merck For CMX157, A Novel Candidate For The Treatment Of HIV
7. Chimerixs Broad Spectrum Antiviral Therapeutic, CMX001, Demonstrates Potential To Mitigate BK Virus Associated End-Organ Disease In Clinical Study
8. Chimerix Announces BK Virus Data In Late-Breaking Poster Session At The 24th International Congress Of The Transplantation Society
9. Vermillion Appoints Thomas McLain as President and Chief Executive Officer
10. Echo Therapeutics Appoints Robert Doman to Board of Directors
11. CIVCO Appoints Hap Peterson Vice President of North American Sales for Radiation Oncology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... June 2, 2015 Northstar Global Business ... and multi-media commercial advertisement, which it plans to ... SNORenz®, the company,s top selling product. ... past success with television advertising. Previous ads focused ... more modern version takes an entertainment-oriented path, and ...
(Date:6/2/2015)... -- A new report by the Global ... people across 13 countries bring an end to open ... latest Progress Report details how its financial support for ... 20,500 communities become open-defecation free, improved toilets for 4.2 ... to hand-washing facilities. The Progress Report highlights ...
(Date:6/2/2015)... , June 2, 2015 ... American Society of Clinical Oncology    PharmaMar ... 3 SAR3007, resi noti dal dipartimento Ricerca e sviluppo ... significativo miglioramento della sopravvivenza libera da progressione (PFS) dopo ... trattamento con dacarbazina in pazienti con liposarcoma (LPS) o ...
Breaking Medicine Technology:Northstar releases its direct response multi-media ad designed to be used in national television advertising campaigns 2Global Sanitation Fund Reports Major Sanitation & Hygiene Advances for Seven Million People in 13 Countries 2PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 2PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 3PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 4PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 5PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 6
... 18, 2011 What:   ... analysis of FDA,s 510(k) regulatory pathway—through which more than ... within it. The study is the most comprehensive survey ... FDA,s Center for Devices and Radiological Health (CDRH) is ...
... DIEGO, May 18, 2011 aTyr Pharma ... that Melissa Ashlock, M.D., has joined as vice ... Ashlock,s experience in translating novel biology into drug ... team in the development of innovative therapeutic approaches ...
Cached Medicine Technology:Findings From Largest Industry Assessment of 510(k) Process to be Released on May 24, 2011 2Translational Science Expert, Dr. Melissa Ashlock, Joins aTyr Pharma to Advance Physiocrine-based Therapeutics 2Translational Science Expert, Dr. Melissa Ashlock, Joins aTyr Pharma to Advance Physiocrine-based Therapeutics 3
(Date:6/2/2015)... 02, 2015 Date: Thursday, June 4, ... Council Chamber, 494 N. Broad Street, 4th floor, Philadelphia, ... Hepatitis B Foundation will visit Philadelphia City Council ... hepatitis B and hepatitis C in Philadelphia’s at-risk populations. ... they have created, Hep B United Philadelphia (HBUP), will ...
(Date:6/2/2015)... 02, 2015 While the movie box ... comic books, comic books themselves are stepping into a ... Nations plans to produce educational comics in multiple languages ... for Sustainable Development - an international effort to address ... health, education, sustainable energy, inequality, climate change and more. ...
(Date:6/2/2015)... Hanover, MA (PRWEB) June 02, 2015 Join ... 1st Anniversary Awareness Walk in Honor of Rhonda Martin , ... Family members have since dedicated their resources to raising awareness ... family seeks to raise awareness in hopes that there will ... aneurysm. , All are welcome and encouraged to join the ...
(Date:6/2/2015)... Pacifica Graduate Institute announces the ... and former students to honor the memory of Dr. ... until his death in 2013. His students adored Dr. ... as well as his passion for politics, Zen meditation, ... teacher, and writer were felt in his presence and ...
(Date:6/2/2015)... CA (PRWEB) June 02, 2015 “We want ... damaging ultraviolet (UV) sun rays”, states Marta Phillips, owner of ... of men’s sun hats and sun accessories that work well ... are not immediately evident. Sometimes sun damage can take up ... and neck are prime areas for skin cancer to occur. ...
Breaking Medicine News(10 mins):Health News:Hepatitis B Foundation to Urge Philadelphia Leaders to Make Viral Hepatitis Prevention a Local Priority 2Health News:Can Comics Help the United Nations Save the World? 2Health News:Can Comics Help the United Nations Save the World? 3Health News:New Awareness Raising Event in Westwood, NJ to Benefit Renowned Brain Aneurysm Foundation 2Health News:Pacifica Graduate Institute - Mythological Studies Students Establish Memorial Scholarship to Honor Dr. V. Walter Odajnyk 2Health News:Pacifica Graduate Institute - Mythological Studies Students Establish Memorial Scholarship to Honor Dr. V. Walter Odajnyk 3Health News:It is Time to Show Father Who Knows Best, Says SunGrubbies.com, a Leading Online Sun Protection Retailer 2
... floor disorders involve a weakening of the muscles or ... surgery for pelvic-floor disorders many of the activities are ... vagina, whereas in severe cases, they may actually protrude ... exercises for mild cases and surgery for more severe ...
... rapid, significant improvement in patients with moderate to severe ... dose-ranging from 3 mg/kg and 5 mg/kg. The continuous ... clearance compared with as-needed therapy regimens within each dose. ... 70 % of the patients treated with Remicade 3 ...
... from the United States and France has discovered a mouse ... led to the // race among scientists to find a ... out and destroy cancer have to be designed. ... at the Johns Hopkins Kimmel Cancer Center says that this ...
... A group of friends and family frustrated with dieting and ... motivate them to lose more than 75 lbs. over a ... participants to lose over 75 lbs, exercise more than 25 ... their original body weight., ,The competition began with Jen ...
... Contact dermatitis is an allergic reaction caused to many human ... causes of // allergic contact dermatitis. The exact definition of ... in swollen, reddened and itchy skin due to direct contact ... the mayo study are as follows:- ,? Nickel (nickel ...
... Professionals Follow-up Study has gathered data on men's health over ... in 2000 to what is a semi annual survey.// Judging ... there are some useful pointers on how men can maintain ... ,Sexual dysfunction is the most prevalent illness in elderly ...
Cached Medicine News:Health News:Clinical Impact of Activity and Abdominal Pressure on Pelvic Floor Dysfunction Need to Be Further Analyzed 2Health News:Two in One Cell Offers Hope to Find a Cure for Cancer 2
... Designed To Rest Either Nasally Or ... Over, Allowing Eyelids To Be Opened ... Widest Possible Aperture.,Open And Close With ... To The Globe During Clear Corneal ...
... Handle, Designed To Dial An Exact Extension ... Allows Maximum Visibility, With Titanium Handle & ... Better In Tissue, And Can Also Be ... Paracentesis., ,Reusable, Autoclaveable, Made In The USA, Handle ...
2.5V Halogen source, fiber-optic delivery, 2.5X magnification....
All Keeler otoscopes have bright halogen illumination for clear and accurate visualization of aural canal. Lithium-ion batteries with quick recharge capability. Ring rheostat for fine control of il...
Medicine Products: